Ethicare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 1.89 M
as on 23-10-2024
- Company Age 31 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 61.43 Cr
as on 23-10-2024
- Revenue 32.05%
(FY 2023)
- Profit -33.37%
(FY 2023)
- Ebitda 10.97%
(FY 2023)
- Net Worth 1.92%
(FY 2023)
- Total Assets -12.92%
(FY 2023)
About Ethicare Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.89 M.
The company has closed loans amounting to ₹61.43 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajnikant Dadhich and Shivam Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ1993PTC019386
- Company No.
019386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ethicare Pharmaceuticals Private Limited offer?
Ethicare Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Antipyretic Medication, Paracetamol Tablets, Weight Loss Supplement, Methylcobalamin Tablets, Allopathic Cough Syrup, Dextromethorphan Cough Syrup.
Who are the key members and board of directors at Ethicare Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnikant Dadhich  | Director | 12-Apr-2017 | Current |
| Shivam Patel | Director | 04-Feb-2023 | Current |
Financial Performance of Ethicare Pharmaceuticals.
Ethicare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.05% increase. The company also saw a substantial fall in profitability, with a 33.37% decrease in profit. The company's net worth moved up by a moderate rise of 1.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ethicare Pharmaceuticals?
In 2023, Ethicare Pharmaceuticals had a public holding of 95.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 08 Feb 2019 | ₹5.98 Cr | Satisfied |
The South Indian Bank Limited Creation Date: 14 Dec 2018 | ₹6.30 Cr | Satisfied |
Others Creation Date: 31 Jul 2017 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Ethicare Pharmaceuticals?
Unlock and access historical data on people associated with Ethicare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ethicare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ethicare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
